1naresh
Array
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
1nareshArray
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
Table 1: Clinical outcome in the 15 patients enrolled in the trial, measured in terms of the Clinical Rating Scale for Tremora
Time Point Mean SD Minimum Maximum Baseline CRST 54.9 14.4 38 87 24-Hour CRST 19.3 10.8 5 43 1-Week CRST 18.5 11.0 6 43 1-Month CRST 18.7 12.0 2 39 3-Month CRST 20.3 11.0 6 37 Outcomes (difference between baseline and 3-month CRST) 34.6 10.4 13 50
↵a Lower score is favorable; higher score is unfavorable.